rs142286944

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198576.4(AGRN):​c.4977-10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0257 in 1,612,724 control chromosomes in the GnomAD database, including 655 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 51 hom., cov: 33)
Exomes 𝑓: 0.026 ( 604 hom. )

Consequence

AGRN
NM_198576.4 intron

Scores

2
Splicing: ADA: 0.00002238
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.27

Publications

3 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-1050417-A-G is Benign according to our data. Variant chr1-1050417-A-G is described in ClinVar as Benign. ClinVar VariationId is 263193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0185 (2807/152140) while in subpopulation NFE AF = 0.0304 (2068/67924). AF 95% confidence interval is 0.0294. There are 51 homozygotes in GnomAd4. There are 1299 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 51 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.4977-10A>G intron_variant Intron 28 of 35 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.4977-10A>G intron_variant Intron 28 of 35 1 NM_198576.4 ENSP00000368678.2 O00468-6
AGRNENST00000651234.1 linkc.4662-10A>G intron_variant Intron 27 of 37 ENSP00000499046.1 A0A494C1I6
AGRNENST00000652369.2 linkc.4662-10A>G intron_variant Intron 27 of 34 ENSP00000498543.1 A0A494C0G5
AGRNENST00000620552.4 linkc.4563-10A>G intron_variant Intron 28 of 38 5 ENSP00000484607.1 A0A087X208

Frequencies

GnomAD3 genomes
AF:
0.0185
AC:
2812
AN:
152022
Hom.:
52
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00464
Gnomad AMI
AF:
0.0736
Gnomad AMR
AF:
0.0117
Gnomad ASJ
AF:
0.0158
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0244
Gnomad FIN
AF:
0.00923
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0304
Gnomad OTH
AF:
0.0125
GnomAD2 exomes
AF:
0.0184
AC:
4542
AN:
247310
AF XY:
0.0191
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.00834
Gnomad ASJ exome
AF:
0.0169
Gnomad EAS exome
AF:
0.0000553
Gnomad FIN exome
AF:
0.00979
Gnomad NFE exome
AF:
0.0278
Gnomad OTH exome
AF:
0.0197
GnomAD4 exome
AF:
0.0265
AC:
38659
AN:
1460584
Hom.:
604
Cov.:
34
AF XY:
0.0265
AC XY:
19230
AN XY:
726614
show subpopulations
African (AFR)
AF:
0.00373
AC:
125
AN:
33478
American (AMR)
AF:
0.00862
AC:
385
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.0183
AC:
477
AN:
26106
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39692
South Asian (SAS)
AF:
0.0207
AC:
1784
AN:
86254
European-Finnish (FIN)
AF:
0.00934
AC:
489
AN:
52362
Middle Eastern (MID)
AF:
0.0135
AC:
78
AN:
5766
European-Non Finnish (NFE)
AF:
0.0304
AC:
33828
AN:
1111878
Other (OTH)
AF:
0.0247
AC:
1491
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2597
5193
7790
10386
12983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1260
2520
3780
5040
6300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0185
AC:
2807
AN:
152140
Hom.:
51
Cov.:
33
AF XY:
0.0175
AC XY:
1299
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00462
AC:
192
AN:
41526
American (AMR)
AF:
0.0116
AC:
178
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0158
AC:
55
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.0242
AC:
117
AN:
4828
European-Finnish (FIN)
AF:
0.00923
AC:
98
AN:
10612
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0304
AC:
2068
AN:
67924
Other (OTH)
AF:
0.0123
AC:
26
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
142
284
426
568
710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0233
Hom.:
13
Bravo
AF:
0.0173
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 06, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.86
DANN
Benign
0.45
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000022
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142286944; hg19: chr1-985797; API